BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 12542446)

  • 1. Pitfalls of CD45 gating strategies in leukaemia immunophenotyping.
    Lock RJ; Virgo PF; Evely RS
    Clin Lab Haematol; 2003 Feb; 25(1):67. PubMed ID: 12542446
    [No Abstract]   [Full Text] [Related]  

  • 2. Gating strategy for immunophenotyping of leukemia and lymphoma.
    Sun T; Sangaline R; Ryder J; Gibbens K; Rollo C; Stewart S; Rajagopalan C
    Am J Clin Pathol; 1997 Aug; 108(2):152-7. PubMed ID: 9260755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunophenotyping of acute leukemia: utility of CD45 for blast cell identification.
    Vial JP; Lacombe F
    Methods Cell Biol; 2001; 64():343-58. PubMed ID: 11070847
    [No Abstract]   [Full Text] [Related]  

  • 4. Flow cytometric analysis of aberrant antigen expression of blasts using CD45 blast gating for minimal residual disease in acute leukemia and high-risk myelodysplastic syndrome.
    Ito S; Ishida Y; Murai K; Kuriya S
    Leuk Res; 2001 Mar; 25(3):205-11. PubMed ID: 11226515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analyses of quality assessment studies using CD45 for gating lymphocytes for CD3(+)4(+)%.
    Gelman R; Wilkening C
    Cytometry; 2000 Feb; 42(1):1-4. PubMed ID: 10679736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of hairy cell leukaemia in blood and bone marrow using multidimensional flow cytometry with CD45-PECy5 and SS gating.
    Tytherleigh L; Taparia M; Leahy MF
    Clin Lab Haematol; 2001 Dec; 23(6):385-90. PubMed ID: 11843886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [CD45-gating for flow cytometric immunophenotyping of leukemia].
    Cui W; Ma W; Lin Q
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2000 Apr; 22(2):199-203. PubMed ID: 12903529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flow cytometry CD45 gating for immunophenotyping of acute myeloid leukemia.
    Lacombe F; Durrieu F; Briais A; Dumain P; Belloc F; Bascans E; Reiffers J; Boisseau MR; Bernard P
    Leukemia; 1997 Nov; 11(11):1878-86. PubMed ID: 9369421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. U.S.-Canadian Consensus recommendations on the immunophenotypic analysis of hematologic neoplasia by flow cytometry: selection of antibody combinations.
    Stewart CC; Behm FG; Carey JL; Cornbleet J; Duque RE; Hudnall SD; Hurtubise PE; Loken M; Tubbs RR; Wormsley S
    Cytometry; 1997 Oct; 30(5):231-5. PubMed ID: 9383096
    [No Abstract]   [Full Text] [Related]  

  • 10. U.S.-Canadian Consensus recommendations on the immunophenotypic analysis of hematologic neoplasia by flow cytometry: standardization and validation of laboratory procedures.
    Stelzer GT; Marti G; Hurley A; McCoy P; Lovett EJ; Schwartz A
    Cytometry; 1997 Oct; 30(5):214-30. PubMed ID: 9383095
    [No Abstract]   [Full Text] [Related]  

  • 11. External quality assessment in clinical cell analysis by flow cytometry. Why is it so important?
    Siftar Z; Paro MM; Sokolić I; Nazor A; Mestrić ZF
    Coll Antropol; 2010 Mar; 34(1):207-17. PubMed ID: 20432753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunophenotyping of acute leukemia by flow cytometric analysis. Use of CD45 and right-angle light scatter to gate on leukemic blasts in three-color analysis.
    Borowitz MJ; Guenther KL; Shults KE; Stelzer GT
    Am J Clin Pathol; 1993 Nov; 100(5):534-40. PubMed ID: 8249893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Cytometry on both sides of the Atlantic, 2011.
    Preffer FI; Gratama JW
    Cytometry B Clin Cytom; 2011 Nov; 80(6):373-4. PubMed ID: 22002905
    [No Abstract]   [Full Text] [Related]  

  • 14. A 5-color flow cytometric method for extended 8-part leukocyte differential.
    Guy J; Wagner-Ballon O; Pages O; Bailly F; Borgeot J; Béné MC; Maynadié M
    Cytometry B Clin Cytom; 2017 Nov; 92(6):498-507. PubMed ID: 28321976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. U.S.-Canadian Consensus recommendations on the immunophenotypic analysis of hematologic neoplasia by flow cytometry: data analysis and interpretation.
    Borowitz MJ; Bray R; Gascoyne R; Melnick S; Parker JW; Picker L; Stetler-Stevenson M
    Cytometry; 1997 Oct; 30(5):236-44. PubMed ID: 9383097
    [No Abstract]   [Full Text] [Related]  

  • 16. Consensus protocol for the flow cytometric immunophenotyping of hematopoietic malignancies. Working Group on Flow Cytometry and Image Analysis.
    Rothe G; Schmitz G
    Leukemia; 1996 May; 10(5):877-95. PubMed ID: 8656686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [CD45 gating of acute leukemia].
    Nishikawa K; Miyasaki T; Tsukaguchi N; Noma Y; Nakagawa K; Narita N
    Rinsho Byori; 1996 Jun; 44(6):548-53. PubMed ID: 8752733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Automation for clinical CD4 T-cell enumeration, a desirable tool in the hands of skilled operators.
    Diallo TO; Bergeron M; Seely P; Yang X; Ding T; Plews M; Sandstrom P; Ball TB; Meyers AFA
    Cytometry B Clin Cytom; 2017 Nov; 92(6):445-450. PubMed ID: 26990810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood cell markers.
    Grindem CB
    Vet Clin North Am Small Anim Pract; 1996 Sep; 26(5):1043-64. PubMed ID: 8863390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New methodologic approaches for immunophenotyping acute leukemias.
    Basso G; Buldini B; De Zen L; Orfao A
    Haematologica; 2001 Jul; 86(7):675-92. PubMed ID: 11454522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.